Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page shows a new revision label Revision: v3.6.4, replacing the previous v3.6.3. This indicates a minor maintenance update and does not alter the study history content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe Record History now displays the latest site revision as v3.6.3, replacing the previous v3.6.2, indicating an update to the page's underlying software.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.6.2 was added as the latest entry and Revision: v3.6.0 was removed from the record history. This update reflects a change to the page's revision history rather than substantive content changes.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page history now shows recruitment is closed and the revision label has been updated to v3.6.0, while the previous v3.5.5 entry was removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe revision label at the bottom updated from v3.5.4 to v3.5.5, indicating a newer release of the interface.SummaryDifference0.0%

- Check84 days agoChange DetectedA new site revision entry 'Revision: v3.5.4' appears in the history, replacing the previous 'Revision: v3.5.3'. This indicates a site update rather than a change to the study data or records.SummaryDifference0.0%

Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.